Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· November 26, 2025

Stocks Settle Higher as US Economic News Lifts Fed Rate Cut Expectations

View original at nasdaq.com
Stocks Settle Higher as US Economic News Lifts Fed Rate Cut Expectations The S&P 500 Index ($SPX) (SPY) on Tuesday closed up by +0.91%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up by +1.43%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up by +0.58%…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • An agreement between Meta and Google would suggest Google is making headway in efforts to rival Nvidia's AI accelerator chips

    80% confidence
  • Q1 revenue forecast of $3.0 billion to $3.2 billion

    80% confidence
  • 2026 net sales forecast lowered to +3.5% to +4.5% from previous +3% to +5%

    80% confidence
  • Oracle stock downgraded to hold from buy with price target cut to $230 from $350

    80% confidence
  • Meta Platforms is in talks to spend billions on Google's AI chips (TPUs) in data centers in 2027

    80% confidence
  • Q1 revenue forecast of $1.53 billion to $1.55 billion

    80% confidence
  • 83% of reporting S&P 500 companies exceeded Q3 earnings forecasts, on course for the best quarter since 2021

    80% confidence
  • Full-year comparable sales forecast raised to -2.5% to -3.0% from previous -4% to -5%

    80% confidence
  • 2026 revenue forecast raised to $41.65 billion-$41.95 billion from previous $41.1 billion-$41.9 billion

    80% confidence
  • 2026 revenue forecast raised to $4.85 billion-$4.86 billion from previous $4.83 billion-$4.84 billion

    80% confidence
  • Q3 earnings rose +14.6%, more than doubling expectations of +7.2% y/y

    80% confidence
  • Q1 revenue forecast of $610 million to $630 million

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
Stocks Settle Higher as US Economic News Lifts Fed Rate Cut Expectations — Source | Via News | ViaNews Market